Lilly Announces Program to Provide Insulin at Discounted Prices
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- S&P 500, Nasdaq decline as Iran tensions jolt sentiment; chip stocks fall
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 4% as Trump says US reinstating Iran naval blockade
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- S&P 500, Nasdaq decline as Iran tensions jolt sentiment; chip stocks fall
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Japan has no plans to overhaul pension funds' asset allocation, sources say
Mizuho Securities Remains Sidelined on Express Scripts (ESRX) Following 2017 Guidance
December 14, 2016 1:16 PM ESTMizuho Securities reiterated a Neutral rating and $76.00 price target on Express Scripts (NASDAQ: ESRX) following the company's initial 2017 guidance. 2017 adjusted EPS guidance is $6.82-$7.02, relatively in-line with consensus of $6.93 at the midpoint ($6.92), implies a +7-10% adjusted EPS growth y/y.
Analyst Ann Hynes commented,... More
